ID
16030
Description
Documentation part: SIRS & Nasal swab A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline
Keywords
Versions (1)
- 6/26/16 6/26/16 -
Uploaded on
June 26, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
SIRS & Nasal swab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
SIRS & Nasal swab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Description
Culture Results for Nasal Swab (NASAL)
Description
Pathogen Isolation for Nasal Swab (NASAL_P)
Description
Isolate number
Data type
integer
Alias
- UMLS CUI [1,1]
- C1764827
- UMLS CUI [1,2]
- C0449788
Description
Quantitation
Data type
text
Alias
- UMLS CUI [1]
- C0368993
- UMLS CUI [2]
- C0427944
Description
Identification
Data type
text
Alias
- UMLS CUI [1]
- C1982072
Description
If "other", specify:
Data type
text
Alias
- UMLS CUI [1]
- C0205394
Description
If pathogen(s) was recovered, were isolates sent from the local laboratory to the Central Laboratory (QUEST)?
Data type
text
Description
If "no", specify reason:
Data type
text
Alias
- UMLS CUI [1]
- C0392360
Similar models
SIRS & Nasal swab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
C0021368 (UMLS CUI [2])
C0681889 (UMLS CUI [1,2])
C0037278 (UMLS CUI [1,3])
C2061903 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,2])
C0427944 (UMLS CUI [2])